NICE turns down GSK’s IV Benlysta for systemic lupus
The cost watchdog said uncertain trial evidence and cost-effectiveness estimates are behind the preliminary decision
Read More
Tag: systemic lupus
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
